Warner Chilcott Cash from Operations Quarterly:
349.00M for Dec. 31, 2012Warner Chilcott Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 349.00M |
| Sept. 30, 2012 | 184.00M |
| June 30, 2012 | 156.00M |
| March 31, 2012 | 208.00M |
| Dec. 31, 2011 | 394.00M |
| Sept. 30, 2011 | 251.00M |
| June 30, 2011 | 260.00M |
| March 31, 2011 | 272.00M |
| Dec. 31, 2010 | 332.16M |
| Sept. 30, 2010 | 250.18M |
| June 30, 2010 | 119.85M |
| March 31, 2010 | 245.24M |
| Dec. 31, 2009 | 163.76M |
| Sept. 30, 2009 | 111.05M |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
WCRX Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Actavis | 218.60M |
| Mylan | 87.56M |
| Valeant Pharmaceuticals International | 255.35M |
WCRX Cash from Operations Quarterly Rankings
| Overall |
95th percentile 332 of 7593 |
| Sector |
96th percentile 23 of 650 in Healthcare |
| Industry |
96th percentile 2 of 65 in Drug Manufacturers - Specialty & Generic |
WCRX Cash from Operations Quarterly Range, Past 5 Years
| Minimum | 90.04M | Sep 2008 |
| Maximum | 394.00M | Dec 2011 |
| Average | 202.22M |
